Protein-based sample collection matrices and devices
US-2017327815-A1 · Nov 16, 2017 · US
US2022372086A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2022372086-A1 |
| Application number | US-202017636721-A |
| Country | US |
| Kind code | A1 |
| Filing date | Sep 16, 2020 |
| Priority date | Sep 16, 2019 |
| Publication date | Nov 24, 2022 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present disclosure relates to methods of isolating and purifying synthetic block copolymer proteins via the application of solvents and high shear microfluidization methods.
Opening claim text (preview).
1 . A method of isolating a recombinant spider silk protein from a host cell, comprising: a. providing an insoluble mass comprising a recombinant spider silk protein; b. adding the insoluble mass to an aqueous solution comprising a solvent; and c. applying a shear force to the aqueous solution comprising the insoluble mass thereby solubilizing the recombinant spider silk protein in the aqueous solution. 2 . The method of claim 1 , wherein the shear force is applied via microfluidization. 3 . The method of claim 2 , wherein the microfluidization generates shear rates of about 6×10 6 s −1 to 10×10 6 s −1 . 4 .- 5 . (canceled) 6 . The method of claim 2 , wherein the microfluidization is performed at between 20,000 psi to 30,000 psi. 7 .- 8 . (canceled) 9 . The method of claim 2 , wherein the microfluidizer an M-110P or an LM10 microfluidizer. 10 .- 11 . (canceled) 12 . The method of claim 1 , wherein the shear force is applied at least twice. 13 .- 15 . (canceled) 16 . The method of claim 1 , wherein the insoluble mass is derived from a cell culture comprising a host cell, wherein the host cell expresses the recombinant spider silk protein, and the method further comprises collecting the insoluble mass derived from the cell culture. 17 . (canceled) 18 . The method of claim 1 , wherein the solvent is a chaotropic agent. 19 . The method of claim 18 , wherein the chaotropic agent is urea, guanidine thiocyanate (GdnSCN), or guanidine chloride (GdnHCL). 20 . The method of claim 1 , wherein the insoluble mass is added to the aqueous solution at about a 5%, 10%, 15%, 20%, 25%, or 30% insoluble mass to solvent volume. 21 . The method of claim 19 , wherein the chaotropic agent is present in the aqueous solution at a concentration from 0.1-10M. 22 . The method of claim 19 , wherein the aqueous solution comprises about 10M urea, about 4M-8M GdnHCl, or about 3M-6M GdnSCN. 23 .- 24 . (canceled) 25 . The method of claim 20 , wherein the aqueous solution comprises about a 15% insoluble portion mass to an 85% volume of 3M GdnSCN. 26 . The method of claim 20 , wherein the aqueous solution comprises about a 15% insoluble portion mass to an 85% volume of 4M GdnHCI. 27 . The method of claim 20 , wherein the aqueous solution comprises about a 15% insoluble portion mass to an 85% volume of 10M urea. 28 . The method of claim 1 , wherein the insoluble mass is incubated between 20° C. and 30° C. 29 .- 30 . (canceled) 31 . The method of claim 1 , wherein the insoluble portion is incubated in the aqueous solution comprising the solvent for 60 to 120 minutes. 32 .- 35 . (canceled) 36 . The method of claim 1 , wherein the insoluble mass comprises a cell pellet, and method further comprises: a. incubating the cell pellet with a solution comprising 4M urea at a 10:1 urea volume to pellet mass ratio; and b. centrifuging the solution comprising 4M urea to obtain a second cell pellet prior to incubating the second cell pellet in the aqueous solution comprising a solvent. 37 . The method of claim 1 , further comprising isolating the recombinant spider silk protein from the aqueous solution, thereby producing an isolated recombinant spider silk protein. 38 . The method of claim 1 , wherein the recombinant spider silk protein is a highly crystalline silk protein, a high beta sheet content silk protein, or a low solubility silk protein. 39 . The method of claim 38 , wherein the recombinant spider silk protein comprises the Uloborus diversus MiSP protein as set forth in SEQ ID NO: 23. 40 . The method of claim 38 , wherein the recombinant spider silk protein has a solubility threshold of less than 90%, 80%, 70%, 60%, or 50% in a non-chaotropic solvent. 41 . (canceled) 42 . The method of claim 1 , wherein the cell is Escherichia coli. 43 .- 44 . (canceled) 45 . The method of claim 1 , wherein the isolated recombinant spider silk protein is full-length recombinant spider silk protein. 46 .- 48 . (canceled) 49 . The method of claim 1 , wherein the purity of the isolated recombinant spider silk protein is 5-10%, 10-15%, 15-20%, 20-25%, 25-30%, 30-35%, 35-40%, 45-50%, 50-55%, 55-60%, 60-65%, 65-70%, 70-75%, 75-80%, 80-85%, 85-90%, 09-95%, or 95-100%. 50 . A method of isolating a recombinant spider silk protein from a host cell, comprising: a. providing an insoluble mass comprising a recombinant spider silk protein; b. adding the insoluble mass to an aqueous solution comprising a solvent, wherein the aqueous solution comprises 15% (w/v) insoluble portion in a final 10M urea concentration; c. applying a shear force via microfluidization to the aqueous solution comprising the insoluble mass thereby solubilizing the recombinant spider silk protein in the aqueous solution; and d. isolating the recombinant spider silk protein from the aqueous solution, thereby producing an isolated recombinant spider silk protein. 51 . A method of isolating a recombinant spider silk protein from a host cell, comprising: a. providing an insoluble mass comprising a recombinant spider silk protein; b. adding the insoluble mass to an aqueous solution, wherein the aqueous solution comprises about a 15% (w/v) insoluble portion in a final 10M urea concentration; c. applying a shear force via microfluidization, wherein the shear force is about 10×10 6 s −1 , to the aqueous solution thereby solubilizing the recombinant spider silk protein in the aqueous solution; and d. isolating the recombinant spider silk protein from the aqueous solution, thereby producing an isolated recombinant spider silk protein. 52 . A composition comprising a recombinant spider silk protein produced by the method of claim 1 . 53 . (canceled) 54 . A silk fiber comprising a recombinant spider silk protein produced by the method of claim 1 .
Silk · CPC title
from spiders · CPC title
Monocomponent artificial filaments or the like of proteins; Manufacture thereof · CPC title
containing ingredients of undetermined constitution or reaction products thereof {, e.g. transplant tissue, natural bone, extracellular matrix (isolated natural compounds, e.g. collagen A61L27/24)} · CPC title
containing a His-tag · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.